Neurovascular coupling (NVC) is important for brain function and its dysfunction underlies many neuropathologies. Although cell-type specificity has been implicated in NVC, how active neural information is conveyed to the targeted arterioles in the brain remains poorly understood. Here, using two-photon focal optogenetics in the mouse cerebral cortex, we demonstrate that single glutamatergic axons dilate their innervating arterioles via synaptic-like transmission between neural–arteriolar smooth muscle cell junctions (NsMJs). The presynaptic parental–daughter bouton makes dual innervations on postsynaptic dendrites and on arteriolar smooth muscle cells (aSMCs), which express many types of neuromediator receptors, including a low level of glutamate NMDA receptor subunit 1 (Grin1). Disruption of NsMJ transmission by aSMC-specific knockout of GluN1 diminished optogenetic and whisker stimulation-caused functional hyperemia. Notably, the absence of GluN1 subunit in aSMCs reduced brain atrophy following cerebral ischemia by preventing Ca2+ overload in aSMCs during arteriolar constriction caused by the ischemia-induced spreading depolarization. Our findings reveal that NsMJ transmission drives NVC and open up a new avenue for studying stroke.
Human hypothalamus is central to basic physiological functions and its dysfunction is associated with many diseases, yet its spatial cellular and molecular architecture remains poorly understood. Here we present a comprehensive 3D atlas of the adult human hypothalamus aligned to magnetic resonance imaging (MRI) data, integrating spatial transcriptomics, single-nucleus RNA sequencing, and histological analysis. Cross-species comparisons identified homologous regions and subregions between human and mouse hypothalamus. We found that adult human hypothalamus maintained a conserved spatial pattern of transcription factors along the anteroposterior axis established during early development. Furthermore, we uncovered a more segregated neuronal organization in human hypothalamus than mouse and distinctive human features in various hypothalamic nuclei. Finally, we identified the disease landscape in human hypothalamus. Together, our atlas revealed the spatial cellular and molecular organization of the human hypothalamus, helping to bridge experimental animal studies and human clinical investigation.
The Calcitonin gene-related peptide (CGRP) receptor has gained attention in Alzheimer’s Disease (AD) research due to its involvement in regulating neuroinflammation, but its role and mechanism in AD pathology remain unclear. Here, we demonstrate that CALCRL, a core component of the CGRP receptor, is upregulated in the hippocampus of AD dementia patients and 5×FAD mice. Knockout of the CGRP receptor ligand Calca or pharmacological blockade using Rimegepant (Rim), attenuates soluble Aβ1-42 oligomer-induced neuronal death and glial inflammation, and ameliorates neurobehavioral deficits and AD pathology in 5×FAD mice. Mechanistically, these effects are mediated through HDAC11 inhibition, which enhances LXRβ acetylation and ABCA1 expression, reprogramming the lipid metabolism of neurons and glia. Importantly, the CALCRL/HDAC11/LXRβ/ABCA1 axis is conserved across both humans and mice. Our data uncover a novel mechanism underlying AD pathogenesis and highlight the therapeutic potential of targeting CGRP signaling in AD.